Literature DB >> 14593090

Neuroactive steroid interactions with voltage-dependent anion channels: lack of relationship to GABA(A) receptor modulation and anesthesia.

Ramin Darbandi-Tonkabon1, Brad D Manion, William R Hastings, William J Craigen, Gustav Akk, John R Bracamontes, Yejun He, Tatiana V Sheiko, Joseph H Steinbach, Steven J Mennerick, Douglas F Covey, Alex S Evers.   

Abstract

Neuroactive steroids modulate the function of gamma-aminobutyric acid type A (GABA(A)) receptors in brain; this is the presumed basis of their action as anesthetics. In a previous study using the neuroactive steroid analog, (3alpha,5beta)-6-azi-3-hydroxypregnan-20-one (6-AziP), as a photoaffinity-labeling reagent, we showed that voltage-dependent anion channel-1 (VDAC-1) was the predominant protein labeled in brain. Antisera to VDAC-1 were shown to coimmunoprecipitate GABA(A) receptors, suggesting a functional relationship between steroid binding to VDAC-1 and modulation of GABA(A) receptor function. This study examines the contribution of steroid binding to VDAC proteins to modulation of GABA(A) receptor function and anesthesia. Photolabeling of 35-kDa protein with [(3)H]6-AziP was reduced 85% in brain membranes prepared from VDAC-1-deficient mice but was unaffected by deficiency of VDAC-3. The photolabeled 35-kDa protein in membranes from VDAC-1-deficient mice was identified by two-dimensional electrophoresis and electrospray ionization-tandem mass spectrometry as VDAC-2. The absence of VDAC-1 or VDAC-3 had no effect on the ability of neuroactive steroids to modulate GABA(A) receptor function as evidenced by radioligand ([(35)S] t-butylbicyclophosphorothionate) binding or by electrophysiological studies. Electrophysiological studies also showed that neuroactive steroids modulate GABA(A) receptor function normally in VDAC-2-deficient fibroblasts transfected with alpha(1)beta(2)gamma(2) GABA(A) receptor subunits. Finally, the neuroactive steroid pregnanolone [(3alpha,5beta)-3-hydroxypregnan-20-one] produced anesthesia (loss of righting reflex) in VDAC-1- and VDAC-3-deficient mice, and there was no difference in the recovery time between the VDAC-deficient mice and wild-type controls. These data indicate that neuroactive steroid binding to VDAC-1, -2, or -3 is unlikely to mediate GABA(A) receptor modulation or anesthesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593090     DOI: 10.1124/jpet.103.058123

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor.

Authors:  Zi-Wei Chen; Brad Manion; R Reid Townsend; David E Reichert; Douglas F Covey; Joe Henry Steinbach; Werner Sieghart; Karoline Fuchs; Alex S Evers
Journal:  Mol Pharmacol       Date:  2012-05-30       Impact factor: 4.436

2.  Click Chemistry Reagent for Identification of Sites of Covalent Ligand Incorporation in Integral Membrane Proteins.

Authors:  Melissa M Budelier; Wayland W L Cheng; Lucie Bergdoll; Zi-Wei Chen; Jeff Abramson; Kathiresan Krishnan; Mingxing Qian; Douglas F Covey; James W Janetka; Alex S Evers
Journal:  Anal Chem       Date:  2017-02-09       Impact factor: 6.986

3.  Mechanisms revealed through general anesthetic photolabeling.

Authors:  Brian P Weiser; Kellie A Woll; William P Dailey; Roderic G Eckenhoff
Journal:  Curr Anesthesiol Rep       Date:  2014-03-01

4.  11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors.

Authors:  Zi-Wei Chen; Cunde Wang; Kathiresan Krishnan; Brad D Manion; Randy Hastings; John Bracamontes; Amanda Taylor; Megan M Eaton; Charles F Zorumski; Joseph H Steinbach; Gustav Akk; Steven Mennerick; Douglas F Covey; Alex S Evers
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

5.  A neurosteroid analogue photolabeling reagent labels the colchicine-binding site on tubulin: a mass spectrometric analysis.

Authors:  Zi-Wei Chen; Li-Hai Chen; Natalia Akentieva; Cheryl F Lichti; Ramin Darbandi; Randy Hastings; Douglas F Covey; David E Reichert; R Reid Townsend; Alex S Evers
Journal:  Electrophoresis       Date:  2012-02       Impact factor: 3.535

6.  Sites and functional consequence of VDAC-alkylphenol anesthetic interactions.

Authors:  Brian P Weiser; Weiming Bu; David Wong; Roderic G Eckenhoff
Journal:  FEBS Lett       Date:  2014-10-18       Impact factor: 4.124

Review 7.  Shedding Light on Anesthetic Mechanisms: Application of Photoaffinity Ligands.

Authors:  Kellie A Woll; William P Dailey; Grace Brannigan; Roderic G Eckenhoff
Journal:  Anesth Analg       Date:  2016-11       Impact factor: 5.108

Review 8.  Mechanisms of neurosteroid interactions with GABA(A) receptors.

Authors:  Gustav Akk; Douglas F Covey; Alex S Evers; Joe Henry Steinbach; Charles F Zorumski; Steven Mennerick
Journal:  Pharmacol Ther       Date:  2007-04-20       Impact factor: 12.310

9.  In vivo activation of azipropofol prolongs anesthesia and reveals synaptic targets.

Authors:  Brian P Weiser; Max B Kelz; Roderic G Eckenhoff
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

10.  Impact of sex differences in brain response to infection with Plasmodium berghei.

Authors:  Mohamed A Dkhil; Esam M Al-Shaebi; Mahmoud Y Lubbad; Saleh Al-Quraishy
Journal:  Parasitol Res       Date:  2015-10-24       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.